Developing a new imaging system for better detection of breast cancer
Self-collimating Single Photon Emission Breast Tomography System with Three-Dimensional Sparse Position-Sensitive Detectors
This study is testing a new type of breast scanner that uses special imaging technology to find breast cancer earlier and more accurately, helping patients get better diagnoses and treatment while keeping radiation exposure low.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-10805488 on NIH RePORTER |
What this research studies
This research focuses on creating a new Single Photon Emission Breast Tomography (SPEBT) scanner designed to improve the early detection of breast cancer. By utilizing radionuclide tracer-based molecular imaging, the system aims to identify cancerous changes at a molecular level before they become visible through traditional imaging methods. The SPEBT scanner boasts enhanced detection efficiency and spatial resolution, significantly improving the ability to detect small tumors and reducing radiation exposure concerns. This innovative approach could lead to more accurate diagnoses and better treatment outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include women at risk for breast cancer or those with early-stage breast cancer who require advanced imaging techniques.
Not a fit: Patients with advanced breast cancer or those who do not require imaging for diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of breast cancer, ultimately improving patient outcomes and survival rates.
How similar studies have performed: Previous research has shown promising results with similar imaging technologies, indicating potential for success with this novel approach.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Yao, Rutao — State University of New York at Buffalo
- Study coordinator: Yao, Rutao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.